东阳光药(06887)拟实施H股全流通

Core Viewpoint - Dongyangguang Pharmaceutical (06887) announced the board's approval to convert 251 million domestic shares into H-shares, representing approximately 43.59% of the total issued share capital as of the announcement date [1] Group 1 - The company plans to apply for the conversion of domestic shares to H-shares, which requires approval from the China Securities Regulatory Commission and the Stock Exchange [1]